Skip Nav Destination
Issues
1 August 2004
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1535-7163
EISSN 1538-8514
Issue Sections
ARTICLE
p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas
Jian-Zhong Qin; Lawrence Stennett; Patricia Bacon; Barbara Bodner; Mary J.C. Hendrix; Richard E.B. Seftor; Elisabeth A. Seftor; Naira V. Margaryan; Pamela M. Pollock; Amy Curtis; Jeffrey M. Trent; Frank Bennett; Lucio Miele; Brian J. Nickoloff
Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer
Daniel E.H. Afar; Vinay Bhaskar; Eric Ibsen; Danna Breinberg; Susan M. Henshall; James G. Kench; Marija Drobnjak; Rick Powers; Melanie Wong; Ferdinand Evangelista; Chris O'Hara; David Powers; Robert B. DuBridge; Ingrid Caras; Ruth Winter; Terri Anderson; Nanette Solvason; Phillip D. Stricker; Carlos Cordon-Cardo; Howard I. Scher; John J. Grygiel; Robert L. Sutherland; Richard Murray; Vanitha Ramakrishnan; Debbie A. Law
Polyomavirus middle T–induced mammary intraepithelial neoplasia outgrowths: Single origin, divergent evolution, and multiple outcomes
Jeannie E. Maglione; Erik T. McGoldrick; Lawrence J.T. Young; Ruria Namba; Jeffrey P. Gregg; Lin Liu; Drew Moghanaki; Lesley G. Ellies; Alexander D. Borowsky; Robert D. Cardiff; Carol L. MacLeod
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model
David Raben; Cataldo Bianco; Vincenzo Damiano; Roberto Bianco; Davide Melisi; Chiara Mignogna; Francesco Paolo D'Armiento; Luca Cionini; A. Raffaele Bianco; Giampaolo Tortora; Fortunato Ciardiello; Paul Bunn
Transcriptome analysis of endometrial cancer identifies peroxisome proliferator-activated receptors as potential therapeutic targets
Cathrine M. Holland; Samir A. Saidi; Amanda L. Evans; Andrew M. Sharkey; John A. Latimer; Robin A.F. Crawford; D. Stephen Charnock-Jones; Cristin G. Print; Stephen K. Smith
Minireview
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds